European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...
Houston Chronicle5d
European committee takes a second look at Alzheimer's drug and now says it should be approved
Biogen said Thursday that the drug, known in the U.S. as Leqembi, received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use as a treatment ...
Bristol Myers Gets CHMP Backing for Augtyro Cancer Drug
Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.
The Globe and Mail4d
Pet owners report extreme alleged side effects from ‘miracle drug’ Librela for arthritic dogs
Librela and a similar drug for use in cats, Solensia, both made by U.S. manufacturer Zoetis Inc., were the first two “monoclonal antibody” products to be authorized as veterinary drugs in ...